Zimmer Names New CEO, CFO
July 28, 2016 at 4:25 p.m.
By -
Dvorak, 43, who had been group president, global businesses and chief legal officer, succeeds Ray Elliott as president and CEO.
Elliott, 57, who served nearly 25 years as a company president and as Zimmer Holdings' chairman, president and CEO since 2001, announced in November that he would retire in the first half of 2007. He will remain chairman of the board until at least November.[[In-content Ad]]"While the years I have spent at Zimmer have been the most rewarding of my career, I determined some time ago that it would be appropriate for me to turn over the day-to-day leadership of the company and spend more time devoted to external boards and transaction-related work," Elliott said.
"Our board conducted a thorough and methodical search for my successor and was unanimous in its selection of David Dvorak. I have had the pleasure of working with David and helping him prepare for the future - we are confident that Zimmer and its shareholders are in excellent hands."
Dvorak said, "I am fully committed to Zimmer's mission and strategic direction and I share our employees' passion to enhance patient quality of life. Under Ray's strong leadership, the growth of Zimmer has been a great business success story and the two of us will be working closely together to facilitate this transition. I am absolutely convinced that our talented management team will continue to execute our plan successfully and generate the strong results expected by both our customers and shareholders."
As group president, global businesses, Dvorak has been responsible for the company's dental, spine, trauma and orthopedic surgical products divisions. In addition to his role as chief legal officer, during his tenure at the company, he also has had global responsibility for business development, human resources, quality assurance, regulatory affairs, clinical affairs, corporate compliance, government affairs and public relations. Dvorak was a principal architect of the company's successful acquisition and integration of Switzerland-based Centerpulse AG.
Dvorak joined Zimmer in 2001, and helped execute the company's successful spin-off from its former parent. He previously was senior vice president, general counsel and secretary of STERIS Corp., a worldwide leader in medical products sterilization and contamination prevention products and services. At STERIS, Dvorak had responsibility for a broad range of global functions. He earlier practiced law with two major firms, with a focus on corporate and securities law, and mergers and acquisitions.
Dvorak received a bachelor's degree in finance from Miami University, Oxford, Ohio, and his law degree, magna cum laude, from Case Western Reserve University School of Law.
Crines named exec VP finance, CFO
Also today, the company announced the appointment of James T. Crines as executive vice president, finance and chief financial officer, replacing Sam R. Leno, 61, who recently notified Zimmer that he is accepting a position with Boston Scientific Corp.
Crines, 48, was first appointed as a corporate officer of Zimmer Holdings in 2001. Most recently he has served as senior vice president, finance, operations and corporate controller and chief accounting officer, with responsibility for internal and external reporting, corporate and business unit accounting, and global operations, manufacturing and logistics.
Crines joined Zimmer in 1997 and was a leader in the early development of the company's strategy for Minimally Invasive Solutions procedures and technologies. He also served as the controller of the company's business in Japan, where he lived with his family. Prior to joining Zimmer from its former parent, Crines served in financial management roles at American Cyanamid and as a senior auditor with PricewaterhouseCoopers. He received his bachelor of science degree in accounting from the University of Scranton and an MBA from the Rutgers Graduate School of Management. He is a Certified Public Accountant.
Zimmer's 2006 sales were approximately $3.5 billion. The company is supported by the efforts of nearly 7,000 employees worldwide.
Dvorak, 43, who had been group president, global businesses and chief legal officer, succeeds Ray Elliott as president and CEO.
Elliott, 57, who served nearly 25 years as a company president and as Zimmer Holdings' chairman, president and CEO since 2001, announced in November that he would retire in the first half of 2007. He will remain chairman of the board until at least November.[[In-content Ad]]"While the years I have spent at Zimmer have been the most rewarding of my career, I determined some time ago that it would be appropriate for me to turn over the day-to-day leadership of the company and spend more time devoted to external boards and transaction-related work," Elliott said.
"Our board conducted a thorough and methodical search for my successor and was unanimous in its selection of David Dvorak. I have had the pleasure of working with David and helping him prepare for the future - we are confident that Zimmer and its shareholders are in excellent hands."
Dvorak said, "I am fully committed to Zimmer's mission and strategic direction and I share our employees' passion to enhance patient quality of life. Under Ray's strong leadership, the growth of Zimmer has been a great business success story and the two of us will be working closely together to facilitate this transition. I am absolutely convinced that our talented management team will continue to execute our plan successfully and generate the strong results expected by both our customers and shareholders."
As group president, global businesses, Dvorak has been responsible for the company's dental, spine, trauma and orthopedic surgical products divisions. In addition to his role as chief legal officer, during his tenure at the company, he also has had global responsibility for business development, human resources, quality assurance, regulatory affairs, clinical affairs, corporate compliance, government affairs and public relations. Dvorak was a principal architect of the company's successful acquisition and integration of Switzerland-based Centerpulse AG.
Dvorak joined Zimmer in 2001, and helped execute the company's successful spin-off from its former parent. He previously was senior vice president, general counsel and secretary of STERIS Corp., a worldwide leader in medical products sterilization and contamination prevention products and services. At STERIS, Dvorak had responsibility for a broad range of global functions. He earlier practiced law with two major firms, with a focus on corporate and securities law, and mergers and acquisitions.
Dvorak received a bachelor's degree in finance from Miami University, Oxford, Ohio, and his law degree, magna cum laude, from Case Western Reserve University School of Law.
Crines named exec VP finance, CFO
Also today, the company announced the appointment of James T. Crines as executive vice president, finance and chief financial officer, replacing Sam R. Leno, 61, who recently notified Zimmer that he is accepting a position with Boston Scientific Corp.
Crines, 48, was first appointed as a corporate officer of Zimmer Holdings in 2001. Most recently he has served as senior vice president, finance, operations and corporate controller and chief accounting officer, with responsibility for internal and external reporting, corporate and business unit accounting, and global operations, manufacturing and logistics.
Crines joined Zimmer in 1997 and was a leader in the early development of the company's strategy for Minimally Invasive Solutions procedures and technologies. He also served as the controller of the company's business in Japan, where he lived with his family. Prior to joining Zimmer from its former parent, Crines served in financial management roles at American Cyanamid and as a senior auditor with PricewaterhouseCoopers. He received his bachelor of science degree in accounting from the University of Scranton and an MBA from the Rutgers Graduate School of Management. He is a Certified Public Accountant.
Zimmer's 2006 sales were approximately $3.5 billion. The company is supported by the efforts of nearly 7,000 employees worldwide.
Have a news tip? Email [email protected] or Call/Text 360-922-3092